Integrated symposium organised and funded by Jazz Pharmaceuticals ASPARAGINASE ACTIVITY MONITORING: KEEPING THE BALL ROLLING Friday 8 May, 2015 12.45 –13.45 Helia Conference Room, Danubius Hotel Helia, Budapest, Hungary AGENDA FACULTY Welcome Professor Martin Schrappe Professor Martin Schrappe Our analytical options: pros and cons Professor Joachim Boos Measuring is knowing: what gets measured gets managed Dr Inge van der Sluis Silent inactivation: incidence, definition and consequences Professor Yves Bertrand What to do with the results: when levels are below 100 IU/L Professor Carmelo Rizzari Overview of the situation in Hungary: why we want to implement AAM Dr Gábor Kovács Summary and closing remarks Professor Martin Schrappe Chair of the International BFM Study Group and Chair of General Paediatrics at University Medical Centre Schleswig-Holstein, Kiel, Germany Professor Joachim Boos Department of Pediatric Hematology and Oncology, Westfälische Wilhelms-Universität Münster, Germany Dr Inge van der Sluis Department of Pediatric Oncology/ Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands Professor Yves Bertrand Pediatric Onco-Hematology Department, IHOP, Lyon, France Professor Carmelo Rizzari University of Milano-Bicocca, Department of Pediatric HematologyOncology, Monza, Italy Dr Gábor Kovács 2nd Department of Paediatrics, Semmelweis University, Budapest, Hungary, and The Hungarian Paediatric Oncology Network A light lunch will be provided prior to the symposium, at 12.00–12.30 in the Jupiter Restaurant (within the hotel). ERW-INT-206-0315-01 Date of preparation: April 2015